New treatment for CLL recommended by NICE
NICE has approved venetoclax with obinutuzumab for people with untreated chronic lymphocytic leukaemia.
News
Read the latest news and views from Lymphoma Action.
Use the drop down filter to find the most relevant news for you.
Lymphoma Management presentations: last chance to watch!
Register before 9am on Monday 5 January for on-demand access to content from our leading event for healthcare professionals.
A Big Give big thank you!
Together we have raised £35,582 from this year’s Big Give Christmas Challenge.
Celebrating International Volunteer Day
Our volunteers are the heart of our mission to make sure no one faces lymphoma alone.
The Big Give Christmas Challenge has started!
Our Big Give Christmas Challenge appeal is now live. Donate between now and midday on 9 December to have your gift doubled, at no extra cost to you.
National Grief Awareness Week
If you're affected by grief, we're here to support you.
In conversation
Have you listened to our podcasts? If not, why not give them a go?
We’re counting down to The Big Give Christmas Challenge!
Donations made through this campaign will be doubled*, at no extra cost to you.
Want to know more about staging of lymphoma?
Find out more in our magazine, Lymphoma Matters.
NICE recommends new treatment for DLBCL
GlofitGemOx now available for people with relapsed or refractory diffuse large B-cell lymphoma (DLBCL).